Round two of the program will provide $249 million to support physicians by providing reimbursement of services necessary for telehealth.
Additional funds will be made available to reimburse physicians for telecommunications services, information services, and connected devices necessary to enable telehealth during COVID19.
The Federal Communications Commission’s Wireline Competition Bureau will begin accepting applications for Round two of the COVID-19 Telehealth Program on April 29, 2021, at noon ET at www.fcc.gov/covid19telehealth. The filing window will last seven days, closing May 6, 2021, at noon ET. Round two of the COVID-19 Telehealth Program is a $249.95 million federal initiative that builds on the $200 million program established as part of the CARES Act.
“For over a year, health care providers have fought on the front lines of this pandemic and have had to rapidly innovate to support the health and well-being of all Americans,” said Acting Chairwoman Jessica Rosenworcel in a statement. “Telehealth has been at the forefront of this effort and I’m pleased to announce that additional support is just around the corner.”
For additional information on eligibility and the application process, go to https://www.usac.org/about/covid-19-telehealth-program/.
This article was originally published on Medical Economics®.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Surge of antidepressant use seen among female adolescents during COVID-19
March 7th 2024A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.
Read More
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More